Anti-Neuroinflammatory Effects of a Semi-Synthetic Isoorientin-Based Glycogen Synthase Kinase-3β Inhibitor in Lipopolysaccharide-Activated Microglial Cells.

Neuroinflammation contributes to the pathogenesis of several neurodegenerative disorders. Glycogen synthase kinase-3β (GSK-3β) regulates the release of proinflammatory cytokines and promotes inflammatory responses in immune cells. Microglia are the resident mononuclear immune cells of the central nervous system. Here, we investigated the anti-neuroinflammatory effects of (2S,3S,4R,5R,6S)-6-(2-(3,4-dimethoxyphenyl)-5,7-dimethoxy-4-oxo-4H-chromen-6-yl)-3,4,5-trihydroxy-N-((S)-1,1,1-trifluoropropan-2-yl)tetrahydro-2H-pyran-2-carboxamide (TFGF-18), a semisynthetic GSK-3β inhibitor, in lipopolysaccharide (LPS) activation of spontaneously immortalized SIM-A9 microglial cells and of mouse cortical microglia. TFGF-18 at 2.5 μM concentration inhibited LPS-induced production of nitric oxide by 56.3% and the proinflammatory cytokines TNF-α and IL-1β by 28.3 and 59.2% in SIM-A9 cells, respectively, relative to the LPS treatment control group. Pretreatment of mouse primary microglial cells with TFGF-18 at 2.5 μM concentration led to a reduction of 58.7% in TNF-α+ microglial cells at 24 h post-LPS stimulation. The migration of LPS-activated SIM-A9 cells was also reduced by 26.7% with pretreatment of TFGF-18 in a scratch assay. Analyses of signaling pathways demonstrated that TFGF-18 led to the suppression of LPS-induced GSK-3β activation and p65/NF-κB activity. Furthermore, the co-culture of SIM-A9 with SH-SY5Y neuroblastoma cells showed the suppression of TFGF-18 to microglia-mediated neurotoxicity in vitro. The findings indicate strong inhibitory effects of TFGF-18 on LPS-induced microglia activation via regulation of GSK-3β and downstream p65/NF-κB signaling. The results suggest a potential role of TFGF-18 in neuroprotection via its anti-neuroinflammatory effect.

• Publication year

  2021

• Venue

  ACS Chemical Neuroscience

• Publication date

  2021-12-16

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1021/acschemneuro.1c00537PMID 34913695
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Isoorientin Affects Markers of Alzheimer's Disease via Effects on the Oral and Gut Microbiota in APP/PS1 Mice.

  2021cited by this paper
• GSK-3 Inhibitors as New Leads to Treat Type-II Diabetes.

  2021cited by this paper
• Isoorientin, a GSK-3β inhibitor, rescues synaptic dysfunction, spatial memory deficits and attenuates pathological progression in APP/PS1 model mice.

  2020cited by this paper
• Isoorientin Inhibits Inflammation in Macrophages and Endotoxemia Mice by Regulating Glycogen Synthase Kinase 3β

  2020cited by this paper
• The Role of GSK-3 in Cancer Immunotherapy: GSK-3 Inhibitors as a New Frontier in Cancer Treatment

  2020cited by this paper
• Structural Basis for Achieving GSK-3 Inhibition with High Potency, Selectivity and Brain Exposure for PET Imaging and Drug Discovery.

  2019cited by this paper
• Dexmedetomidine ameliorates LPS induced acute lung injury via GSK-3β/STAT3-NF-κB signaling pathway in rats.

  2019cited by this paper
• Discovery of Selective, Substrate-Competitive, and Passive Membrane Permeable Glycogen Synthase Kinase-3β Inhibitors: Synthesis, Biological Evaluation, and Molecular Modeling of New C-Glycosylflavones.

  2018cited by this paper
• Anti-neuroinflammatory effects of SLOH in Aβ-induced BV-2 microglial cells and 3xTg-AD mice involve the inhibition of GSK-3β.

  2018cited by this paper
• Microglia in Alzheimer’s disease

  2018cited by this paper
• A dibenzoylmethane derivative inhibits lipopolysaccharide‐induced NO production in mouse microglial cell line BV‐2

  2017cited by this paper
• Production of proinflammatory mediators in activated microglia is synergistically regulated by Notch-1, glycogen synthase kinase (GSK-3β) and NF-κB/p65 signalling

  2017cited by this paper
• Inflammasome activation and innate immunity in Alzheimer's disease

  2017cited by this paper
• How neuroinflammation contributes to neurodegeneration

  2016cited by this paper
• Stress-induced neuroinflammation is mediated by GSK3-dependent TLR4 signaling that promotes susceptibility to depression-like behavior.

  2016cited by this paper
• A Phase II Trial of Tideglusib in Alzheimer's Disease

  2015cited by this paper
• APOE‐modulated Aβ‐induced neuroinflammation in Alzheimer's disease: current landscape, novel data, and future perspective

  2015cited by this paper
• Paroxetine ameliorates lipopolysaccharide-induced microglia activation via differential regulation of MAPK signaling

  2014cited by this paper
• GSK-3 as potential target for therapeutic intervention in cancer

  2014cited by this paper
• A novel cell line from spontaneously immortalized murine microglia.

  2014cited by this paper
• Neuroinflammation: the role and consequences.

  2014cited by this paper
• Isolation and culture of mouse cortical astrocytes.

  2013cited by this paper
• Role of GSK-3β in isoflurane-induced neuroinflammation and cognitive dysfunction in aged rats

  2013cited by this paper
• Differential relationships of reactive astrocytes and microglia to fibrillar amyloid deposits in Alzheimer disease.

  2013cited by this paper
• Regulatory Role of GSK-3β on NF-κB, Nitric Oxide, and TNF-α in Group A Streptococcal Infection

  2013cited by this paper
• Factors regulating microglia activation

  2013cited by this paper
• GSK-3 mediates the release of IL-1β, TNF-α and IL-10 from cortical glia.

  2012cited by this paper
• Microglial phagocytosis induced by fibrillar β-amyloid is attenuated by oligomeric β-amyloid: implications for Alzheimer's disease

  2011cited by this paper
• Glycogen Synthase Kinase-3β: A Mediator of Inflammation in Alzheimer's Disease?

  2011cited by this paper
• Microglial p38a MAPK is a key regulator of proinflammatory cytokine up-regulation induced by toll-like receptor (TLR) ligands or beta-amyloid (Ab)

  2011cited by this paper
• GSK-3 Inhibitors: Preclinical and Clinical Focus on CNS

  2011cited by this paper
• Glycogen synthase kinase-3β inactivation inhibits tumor necrosis factor-α production in microglia by modulating nuclear factor κB and MLK3/JNK signaling cascades

  2010cited by this paper
• An In Vitro Model for Neuroscience: Differentiation of SH-SY5Y Cells into Cells with Morphological and Biochemical Characteristics of Mature Neurons

  2010cited by this paper
• Microglia in neurodegenerative disease

  2010cited by this paper
• Microglial activation and chronic neurodegeneration

  2010cited by this paper
• Mechanisms underlying inflammation in neurodegeneration.

  2010cited by this paper
• Glycogen synthase kinase-3 regulates microglial migration, inflammation, and inflammation-induced neurotoxicity.

  2009cited by this paper
• Brain inflammation and adult neurogenesis: the dual role of microglia.

  2009cited by this paper
• Staphylococcus aureus Induces Microglial Inflammation via a Glycogen Synthase Kinase 3β-Regulated Pathway

  2009cited by this paper
• Differential migration, LPS‐induced cytokine, chemokine, and NO expression in immortalized BV‐2 and HAPI cell lines and primary microglial cultures

  2008cited by this paper
• In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro

  2007cited by this paper
• Microglia-mediated neurotoxicity: uncovering the molecular mechanisms

  2007cited by this paper
• Mechanisms of inflammatory neurodegeneration: iNOS and NADPH oxidase.

  2007cited by this paper
• Toll-like receptor–mediated cytokine production is differentially regulated by glycogen synthase kinase 3

  2005cited by this paper
• Glycogen synthase kinase 3beta functions to specify gene-specific, NF-kappaB-dependent transcription.

  2005cited by this paper
• Glycogen synthase kinase 3 (GSK‐3) inhibitors as new promising drugs for diabetes, neurodegeneration, cancer, and inflammation

  2002cited by this paper
• First non-ATP competitive glycogen synthase kinase 3 beta (GSK-3beta) inhibitors: thiadiazolidinones (TDZD) as potential drugs for the treatment of Alzheimer's disease.

  2002cited by this paper
• A common phosphate binding site explains the unique substrate specificity of GSK3 and its inactivation by phosphorylation.

  2001cited by this paper
• The multifaceted roles of glycogen synthase kinase 3beta in cellular signaling.

  2001cited by this paper
• Lithium Reduces Tau Phosphorylation by Inhibition of Glycogen Synthase Kinase-3*

  1997cited by this paper
• Turnover of resident microglia in the normal adult mouse brain.

  1992cited by this paper
• Relationship of microglia and astrocytes to amyloid deposits of Alzheimer disease.

  1989cited by this paper
• Glycogen Synthase Kinase 3 (cid:2) Functions To Specify Gene-Specific, NF- (cid:3) B-Dependent Transcription

  year unknowncited by this paper

• The mechanism study of isoorientin regulating neuroinflammation after subarachnoid hemorrhage through AKT/GSK3β.

  2026cites this paper
• Characterization of the Proteomic Response in SIM-A9 Murine Microglia Following Canonical NLRP3 Inflammasome Activation

  2026cites this paper
• A co-culture system to study the effects of Poly I:C-activated microglia on the differentiation of murine primary neural stem cells

  2025cites this paper
• GSK3β Substrate-competitive Inhibitors Regulate the gut Homeostasis and Barrier Function to Inhibit Neuroinflammation in Scopolamine-induced Alzheimer’s Disease Model Mice

  2024cites this paper
• Anti-oxidative stress and cognitive improvement of a semi-synthetic isoorientin-based GSK-3β inhibitor in rat pheochromocytoma cell PC12 and scopolamine-induced AD model mice via AKT/GSK-3β/Nrf2 pathway.

  2024cites this paper
• Glycogen synthesis kinase-3β involves in the analgesic effect of liraglutide on diabetic neuropathic pain.

  2023cites this paper
• Akt signaling pathway: a potential therapy for Alzheimer’s disease through glycogen synthase kinase 3 beta inhibition

  2023cites this paper
• Notopterol improves cognitive dysfunction and depression-like behavior via inhibiting STAT3/NF-ĸB pathway mediated inflammation in glioma-bearing mice.

  2023cites this paper